Delivery Order SPE2DB22D2206-SPE2DB24FJA28

Award Date 7/2/24
Potential Completion Date 7/24/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BENLYSTA 400 mg vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024, with a ceiling value of $7,557.00 and a completion date of November 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the Amerisourcebergen Drug Corp, Corporate Office division, which is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $5,586.06 and is a firm fixed-price delivery order, with a period of performance through July 16, 2024. This award is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug BENLYSTA 400 mg vials. The award, valued at $2,519.00, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,258.92 firm fixed-price contract is for the provision of BENLYSTA 400 MG VIALS, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $5,586.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,779.12 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,168.02 firm fixed-price contract has an ultimate completion date of November 19, 2024 and was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award is for the delivery of BENLYSTA 200 mg/mL syringes to the Defense Logistics Agency (DLA). The $5,774.88 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a completion date of January 8, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,519.00 firm fixed-price delivery order is for the supply of BENLYSTA 400 MG vials, a specialty medication. The contract has a period of performance through November 19, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML SYRINGE medication to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $5,581.96 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division. There was no set-aside used for this contract. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJA28
    Delivery Order

This federal contract award is for the delivery of BENLYSTA 120 MG vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,275.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government.

The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/1/24, 12:57 PM